Takeda Pharmaceutical (TAK) Scheduled to Post Earnings on Thursday

Takeda Pharmaceutical (NYSE:TAK) will post its quarterly earnings results before the market opens on Thursday, October 31st. Analysts expect Takeda Pharmaceutical to post earnings of $0.39 per share for the quarter. Investors that are interested in participating in the company’s conference call can do so using this link.

Takeda Pharmaceutical (NYSE:TAK) last announced its quarterly earnings data on Wednesday, July 31st. The company reported $0.56 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.37 by $0.19. Takeda Pharmaceutical had a return on equity of 10.11% and a net margin of 6.02%. The business had revenue of $7.75 billion for the quarter. On average, analysts expect Takeda Pharmaceutical to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year.

Takeda Pharmaceutical Trading Up 1.8 %

TAK opened at $13.85 on Wednesday. The business has a fifty day moving average price of $14.54 and a 200 day moving average price of $13.78. The company has a debt-to-equity ratio of 0.65, a current ratio of 1.26 and a quick ratio of 0.74. Takeda Pharmaceutical has a 12 month low of $12.57 and a 12 month high of $15.08. The stock has a market capitalization of $44.07 billion, a price-to-earnings ratio of 25.18, a PEG ratio of 0.26 and a beta of 0.54.

Takeda Pharmaceutical Company Profile

Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived therapies, immunology, oncology, and neuroscience.